Home/NRx Pharmaceuticals/Michael Abrams

MA

Michael Abrams

Chief Financial Officer

NRx Pharmaceuticals

Therapeutic Areas

Psychiatry Central Nervous System

NRx Pharmaceuticals Pipeline

Drug	Indication	Phase
NRX-101	Suicidal Bipolar Depression (Bipolar Depression with ASIB)	Phase 2/3
NRX-100	Treatment-Resistant Depression with Suicidality	ANDA/NDA Filed

Leadership Team at NRx Pharmaceuticals

Jonathan C. Javitt, M.D., M.P.H.

Founder, Chairman & Chief Scientist; Co-CEO HOPE Therapeutics

View full NRx Pharmaceuticals profile